Log In
Print this Print this

OxyContin, oxycodone

  Manage Alerts
Collapse Summary General Information
Company Purdue Pharma L.P.
DescriptionExtended-release formulation of opioid pain drug
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionOpioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsManage moderate to severe pain; Treat pain
Regulatory Designation
PartnerMundipharma International Ltd.;
Shionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today